BioKinect is a life sciences business development, strategic intelligence and partnering platform created for professionals involved in licensing, technology transfer, corporate strategy, investment and healthcare innovation. It is intended to promote the flow of information around opportunities in the biosciences and healthcare sectors and to help companies identify, evaluate and engage the right partners. ·        Supports business development, licensing and technology professionals ·        Focuses on biosciences, healthcare and life sciences opportunities ·        Uses SAGEIQ to acquire and interpret global public-domain market intelligence ·        Combines technology-enabled discovery with experienced human strategic judgment and networks

SAGEIQ™ is BioKinect’s proprietary AI-enabled strategic intelligence platform designed to transform how partnering opportunities are identified across the global life sciences industry. Powered by the SAGENT™ analytics engine, SAGEIQ systematically searches, analyzes and prioritizes companies, technologies and assets that align with a client’s specific strategic criteria. ·        Purpose-built for healthcare and life sciences strategic intelligence ·        Supports licensing, partnering, market intelligence and M&A opportunity identification ·        Combines AI-driven analytics with more than 30 years of transaction experience ·        Helps identify and prioritize high-value opportunities worldwide

General AI tools are broad language-generation and information-retrieval systems. SAGEIQ is a purpose-built life sciences strategic intelligence and partnering platform. It is designed around structured BD workflows, sector-specific data interpretation, partner qualification and transaction relevance. ·        Generic AI can produce broad answers; SAGEIQ is designed to produce strategically filtered partnering intelligence ·        SAGEIQ integrates scientific, clinical, corporate, competitive, transaction and IP intelligence ·        BioKinect applies human strategic review, commercial interpretation and deal experience to the outputs ·        Goal is not generic information, but actionable partnering precision

Traditional BD searches often rely on manual research, personal networks, conference meetings and broad market scans. SAGEIQ brings a more systematic and data-driven approach by combining AI-enabled analytics with BioKinect’s deep life sciences expertise. ·        Searches across large global datasets, scientific publications, corporate pipelines and transaction histories. ·        Identifies potential partners that may remain undiscovered through conventional BD methods. ·        Improves completeness, precision and speed of partner identification. ·        Reduces dependence on familiar company lists and existing contact circles alone.

AI can dramatically improve speed, visibility and data analysis, but AI alone does not close transactions. Successful partnering requires judgment, credibility, relationships and execution experience. ·        Strategic judgment and commercial interpretation ·        Understanding of scientific, clinical and regulatory realities ·        Executive credibility and relationship networks ·        Negotiation experience and transaction execution ·        Ability to convert data into actionable partnering discussions

Partnering Precision™ is BioKinect’s methodology for combining AI-enabled analysis with expert strategic qualification. Rather than generating large unfiltered lists, SAGEIQ prioritizes relevance, strategic fit and probability of engagement. ·        Focuses on quality rather than volume ·        Ranks opportunities according to strategic fit and likely engagement potential ·        Applies structured criteria to identify high-probability partners ·        Helps clients concentrate resources on the most relevant opportunities first

SAGENT™ is the analytical engine within SAGEIQ. It integrates multiple layers of global life sciences intelligence to support systematic identification and prioritization of partnering opportunities. ·        Aggregates scientific, clinical, corporate, transaction and market intelligence ·        Analyzes companies, assets and technologies against defined strategic criteria ·        Generates targeted partner universes, prioritized opportunities and strategic insights. ·        Supports BioKinect’s AI-enabled Partnering Precision methodology

Healthcare partnering is highly complex. Opportunities must be evaluated not only commercially, but also scientifically, clinically, regulatorily, geographically and strategically. SAGEIQ was built specifically to address this complexity. ·        Rapid innovation cycles ·        Scientific and clinical complexity ·        Evolving competitive landscapes ·        Regulatory and IP considerations ·        Geographic rights structures and local market dynamics ·        Clinical differentiation and commercial positioning requirements

Generic AI engines can be useful for broad research, but they lack the specialist life sciences transaction context required for high-quality partnering decisions. Without expert interpretation, AI outputs can create large amounts of noise rather than actionable intelligence. ·        Generic AI lacks sector-specific BD qualification frameworks. ·        Generic AI does not provide proprietary partnering methodology or transaction execution support. ·        Generic AI lacks human relationship networks and counterparty credibility. ·        Generic AI may miss commercial, regulatory or strategic nuances that determine whether a partner is genuinely relevant.

No. SAGEIQ is designed to enhance and strengthen BD teams, not replace them. It provides a structured, AI-enabled analysis and prioritization layer that enables BD professionals to focus their time on the highest-probability opportunities. ·        Improves global opportunity visibility ·        Increases search efficiency and targeting precision ·        Supports strategic prioritization of opportunities ·        Enables BD teams to move faster with better-qualified target lists